Preserved Versus Preservative-Free Latanoprost for the Treatment of Glaucoma and Ocular Hypertension: A Post Hoc Pooled Analysis

被引:0
|
作者
Paul Harasymowycz
Cindy Hutnik
Jean-François Rouland
Francisco J. Muñoz Negrete
Mario A. Economou
Philippe Denis
Christophe Baudouin
机构
[1] University of Montreal,Ivey Eye Institute
[2] Bellevue Ophthalmology Clinics and Montreal Glaucoma Institute,Ophthalmology Department
[3] Western University,Department of Ophthalmology
[4] University of Lille,undefined
[5] Hospital Ramón y Cajal,undefined
[6] Universidad Alcalá,undefined
[7] Ophthalmology,undefined
[8] Queen Sofia Hospital,undefined
[9] Praktikertjänst,undefined
[10] HEH,undefined
[11] Hospices Civils de Lyon,undefined
[12] Quinze-Vingts National Ophthalmology Hospital,undefined
来源
Advances in Therapy | 2021年 / 38卷
关键词
Open-angle glaucoma; Ocular hypertension; Hyperemia; Ocular surface disease; Intraocular pressure; Latanoprost; Preservative-free; Monoprost; Patient satisfaction;
D O I
暂无
中图分类号
学科分类号
摘要
Preservatives in eye drops for glaucoma can cause side effects such as stinging and eye redness. These side effects can cause some patients to reduce the frequency of the drops as prescribed or stop using the drops. One of the most common drops for glaucoma is latanoprost. This study evaluated whether a preservative-free latanoprost (PFL) is as effective as preservative-containing latanoprost (PCL) for reducing eye pressure and whether PFL is better tolerated in patients with glaucoma. The results of the study indicated that PFL was as effective as PCL for reducing eye pressure. The results also indicated PFL was much better at reducing the side effects related to PCL. For example PFL reduces eye redness up to twofold compared to PCL. By reducing the side effects associated with PCL patients may continue to take their glaucoma drops as directed and thereby reduce the risk of vision loss from glaucoma.
引用
收藏
页码:3019 / 3031
页数:12
相关论文
共 50 条
  • [41] 24-Hour Efficacy and Ocular Surface Health with Preservative-Free Tafluprost Alone and in Conjunction with Preservative-Free Dorzolamide/Timolol Fixed Combination in Open-Angle Glaucoma Patients Insufficiently Controlled with Preserved Latanoprost Monotherapy
    Anastasios-Georgios Konstas
    Konstadinos G. Boboridis
    Paraskevas Kapis
    Konstantinos Marinopoulos
    Irini C. Voudouragkaki
    Dimitrios Panayiotou
    Dimitrios G. Mikropoulos
    Eirini Pagkalidou
    Anna-Bettina Haidich
    Andreas Katsanos
    Luciano Quaranta
    Advances in Therapy, 2017, 34 : 221 - 235
  • [42] Comparisons of efficacy and safety between preserved and preservative-free brimonidine tartrate in glaucoma and ocular hypertension: a parallel-grouped, randomized trial
    Ko Eun Kim
    Chang Kyu Lee
    Jonghoon Shin
    Yuri Kim
    Seungsoo Rho
    Scientific Reports, 13
  • [43] Comparisons of efficacy and safety between preserved and preservative-free brimonidine tartrate in glaucoma and ocular hypertension: a parallel-grouped, randomized trial
    Kim, Ko Eun
    Lee, Chang Kyu
    Shin, Jonghoon
    Kim, Yuri
    Rho, Seungsoo
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [44] Correction to: 24-Hour Efficacy and Ocular Surface Health with Preservative-Free Tafluprost Alone and in Conjunction with Preservative-Free Dorzolamide/Timolol Fixed Combination in Open-Angle Glaucoma Patients Insufficiently Controlled with Preserved Latanoprost Monotherapy
    Anastasios-Georgios Konstas
    Konstadinos G. Boboridis
    Paraskevas Kapis
    Konstantinos Marinopoulos
    Irini C. Voudouragkaki
    Dimitrios Panayiotou
    Dimitrios G. Mikropoulos
    Eirini Pagkalidou
    Anna-Bettina Haidich
    Andreas Katsanos
    Luciano Quaranta
    Advances in Therapy, 2020, 37 : 2572 - 2573
  • [45] Preservative-free tafluprost in the treatment of open-angle glaucoma or ocular hypertension in India: a phase III clinical trial
    Chabi, A.
    Baranak, C.
    Lupinacci, R.
    Herring, W. J.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2016, 70 (07) : 577 - 586
  • [46] Cost-utility analysis of timolol versus latanoprost versus travoprost in the treatment of glaucoma and ocular hypertension
    Lilliu, H
    Le Pen, C
    Berdeaux, G
    VALUE IN HEALTH, 2002, 5 (06) : 552 - 553
  • [47] Efficacy and safety of a new preservative-free fixed combination latanoprost-timolol (T2347) for open-angle glaucoma or ocular hypertension
    Clarke, Jonathan C.
    Lavin-Dapena, Cosme
    Zarnowski, Tomasz
    Pfeiffer, Norbert
    Nordmann, Jean Philippe
    Stalmans, Ingeborg
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2017, 58 (08)
  • [48] Efficacy and tolerability of a preservative-free 0.005% latanoprost in glaucoma patients: a prospective crossover study
    Martin Baiza-Duran, Leopoldo
    Olvera Montano, Oscar
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2018, 59 (09)
  • [49] Preservative-free treatment in glaucoma: who, when, and why?
    Stalmans, Ingeborg
    Megevand, Gordana Sunaric
    Cordeiro, M. Francesca
    Hommer, Anton
    Rossetti, Luca
    Goni, Francisco
    Heijl, Anders
    Bron, Alain
    EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2013, 23 (04) : 518 - 525
  • [50] Randomized Clinical Trial Of The Efficacy And Safety Of Preservative-free Tafluprost And Preservative-free Timolol In Patients With Open-angle Glaucoma (OAG) Or Ocular Hypertension (OHT) In India
    Chabi, Almira
    Lupinacci, Robert
    Baranak, Christine
    Herring, W. Joseph
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2014, 55 (13)